About TECLens
TECLens is a company based in Stamford (United States) founded in 2013.. TECLens has raised $19.94 million across 4 funding rounds from investors including Johnson & Johnson Innovation – JJDC, Yonjin Capital and Rimonci. TECLens offers products and services including qCXL™ Technology and CXLens® Device. TECLens operates in a competitive market with competitors including Adaptilens, Allotex, Presbia, Visco Vision and Shanghai Conant Optical, among others.
- Headquarter Stamford, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Teclens, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$19.94 M (USD)
in 4 rounds
-
Latest Funding Round
$9.3 M (USD), Series A
Feb 11, 2025
-
Investors
Johnson & Johnson Innovation – JJDC
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TECLens
TECLens offers a comprehensive portfolio of products and services, including qCXL™ Technology and CXLens® Device. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Uses UV light to strengthen cornea for treating presbyopia and myopia.
Enables real-time monitoring for precise corneal reshaping procedures.
Funding Insights of TECLens
TECLens has successfully raised a total of $19.94M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $9.3 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $9.3M
-
First Round
First Round
(02 Jun 2017)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Series A - TECLens | Valuation | Johnson & Johnson Innovation – JJDC , Yonjin Capital | |
| May, 2024 | Amount | Series A - TECLens | Valuation | Johnson & Johnson Innovation |
|
| Feb, 2019 | Amount | Seed - TECLens | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TECLens
TECLens has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Johnson & Johnson Innovation – JJDC, Yonjin Capital and Rimonci. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Venture capital firm backed by Yongjin Group
|
Founded Year | Domain | Location | |
|
Limited information is provided about Rimonci's activities.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TECLens
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TECLens
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Teclens Comparisons
Competitors of TECLens
TECLens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adaptilens, Allotex, Presbia, Visco Vision and Shanghai Conant Optical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of intraocular lens
|
|
| domain | founded_year | HQ Location |
Corneal allografts are developed for treating presbyopia and refractive errors.
|
|
| domain | founded_year | HQ Location |
Presbyopia is addressed via the implanted Presbia Flexivue Microlens.
|
|
| domain | founded_year | HQ Location |
Silicone hydrogel-based contact lenses are supplied for vision correction.
|
|
| domain | founded_year | HQ Location |
Optical products for ophthalmic use, including specialized lenses, are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Teclens
Frequently Asked Questions about TECLens
When was TECLens founded?
TECLens was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Where is TECLens located?
TECLens is headquartered in Stamford, United States. It is registered at Stamford, Connecticut, United States.
Is TECLens a funded company?
TECLens is a funded company, having raised a total of $19.94M across 4 funding rounds to date. The company's 1st funding round was a Seed of $200K, raised on Jun 02, 2017.
What does TECLens do?
TECLens was founded in 2013 in Stamford, United States, within the medical device sector focused on ophthalmology. Noninvasive treatments for low myopia are developed, with operations centered on corneal reshaping technologies. The flagship product, CXLens, is utilized to emit patterned ultraviolet light for crosslinking the cornea. Development and testing activities are conducted to advance these vision correction solutions.
Who are the top competitors of TECLens?
TECLens's top competitors include Allotex, Adaptilens and Shanghai Conant Optical.
What products or services does TECLens offer?
TECLens offers qCXL™ Technology and CXLens® Device.
Who are TECLens's investors?
TECLens has 5 investors. Key investors include Johnson & Johnson Innovation – JJDC, Yonjin Capital, Rimonci, Sunmed Capital, and Johnson & Johnson Innovation.